MEC Plus Full List View

MEC Plus

Building the Case for HER-2 Inhibitors in NSCLC
Building the Case for HER-2 Inhibitors in NSCLC
Corey Langer, MD
Brain Radiotherapy in SCLC: When?
Brain Radiotherapy in SCLC: When?
Jeffrey Bradley, MD
Biomarkers for Perioperative Immunotherapy?
Biomarkers for Perioperative Immunotherapy?
David Carbone, MD
Best Surgical Approaches for Stage III NSCLC
Best Surgical Approaches for Stage III NSCLC
Jay M. Lee, MD
Best Approaches for First Line EGFR Mutant NSCLC
Best Approaches for First Line EGFR Mutant NSCLC
Joshua Sabari, MD
ALK in Front Line Therapy: Second or Third Generation TKI Inhibitors. What Can Help Us to Choose the Best Therapeutic Agent?
ALK in Front Line Therapy: Second or Third Generation TKI Inhibitors. What Can Help Us to Choose the Best Therapeutic Agent?
Sai-Hong Ignatius Ou, MD, PhD
Adjuvant Immunotherapy Position
Adjuvant Immunotherapy Position
Christina Baik, MD, MPH
Pulsed Electric Fields
Pulsed Electric Fields
Gloria Hwang, MD
Sarcoma Cryoablation
Sarcoma Cryoablation
Gloria Hwang, MD